Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis

NCT02943447 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
71
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated because of the availability of alternate therapies for primary biliary cholangitis (PBC).

Conditions

Interventions

Sponsor

Gilead Sciences